KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $4.5 million.

  • Medpace Holdings' Capital Expenditures fell 4065.16% to $4.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $31.4 million, marking a year-over-year decrease of 1420.6%. This contributed to the annual value of $31.4 million for FY2025, which is 1420.6% down from last year.
  • Latest data reveals that Medpace Holdings reported Capital Expenditures of $4.5 million as of Q4 2025, which was down 4065.16% from $10.7 million recorded in Q3 2025.
  • Medpace Holdings' Capital Expenditures' 5-year high stood at $12.9 million during Q2 2024, with a 5-year trough of $4.5 million in Q4 2025.
  • Its 5-year average for Capital Expenditures is $8.5 million, with a median of $8.9 million in 2021.
  • As far as peak fluctuations go, Medpace Holdings' Capital Expenditures skyrocketed by 8641.81% in 2022, and later tumbled by 5250.56% in 2025.
  • Medpace Holdings' Capital Expenditures (Quarter) stood at $9.1 million in 2021, then grew by 1.39% to $9.2 million in 2022, then grew by 8.04% to $10.0 million in 2023, then decreased by 23.46% to $7.6 million in 2024, then tumbled by 40.65% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q4 2025, $10.7 million for Q3 2025, and $6.1 million during Q2 2025.